Neurotechnology Agency Boundary / 神经技术能动性边界

Definition

The neurotechnology agency boundary is the ethical requirement that interventions capable of changing desire, emotion, behavior, or personality-relevant traits be judged not only by symptom reduction but also by consent, autonomy, identity continuity, proportionality, and protection against coercive control.

Current Synthesis

The episode reaches this boundary through experimental control of feeding, fear, aggression, and other behavior. If selected neural manipulation can make a fed mouse eat or a hungry mouse stop, technical success does not by itself answer whether an analogous human intervention preserves the person’s goals, values, and authorship of action.

Clinical necessity complicates the line. In severe eating disorders, preventing death may require restoring nutrition even when the patient’s body image and stated wishes remain conflicted. The source therefore does not treat autonomy as a simple veto or symptom relief as a complete justification. It asks whether an intervention is proportionate, evidence-based, consented to where possible, revisable, and directed toward restoring rather than replacing the patient’s agency.

Key Claims

• Technical ability to alter behavior does not by itself establish ethical permission to do so.
• Symptom relief and survival benefit must be assessed alongside autonomy and identity continuity.
• Severe illness can impair or divide expressed preferences, making consent assessment clinically and ethically complex.
• Target specificity does not remove risks of coercion, off-target change, or mistaken interpretation of the desired state.
• Therapeutic intent must be distinguished from social normalization, punishment, convenience, or behavioral control.
• Reversibility, proportionality, evidence, monitoring, and patient participation are central safeguards.

Evidence

• Behavioral control - 用光调控神经细胞：今年诺贝尔奖如何改变我们对情绪的理解？ | 串台「声东击西」S10E32 describes hypothalamic manipulations that change feeding behavior in mice.
• Divided preference - 用光调控神经细胞：今年诺贝尔奖如何改变我们对情绪的理解？ | 串台「声东击西」S10E32 uses eating disorders to show how survival needs, treatment seeking, body perception, and a wish to lose more weight can coexist in one patient.
• Control concern - 用光调控神经细胞：今年诺贝尔奖如何改变我们对情绪的理解？ | 串台「声东击西」S10E32 asks when changing desire, violence-related behavior, or personality traits moves from treatment toward mind control.
• Translation limit - 用光调控神经细胞：今年诺贝尔奖如何改变我们对情绪的理解？ | 串台「声东击西」S10E32 emphasizes that animal behaviors, statistical effects, and precise circuit manipulations do not directly settle human subjective or ethical questions.

Counterevidence & Qualifications

The source poses an ethical framework rather than a complete consent standard, legal rule, or clinical protocol. It does not show that current optogenetics can routinely control human psychiatric states or that all neuromodulation threatens identity. Emergency care, impaired decision-making capacity, reversible interventions, and severe treatment-resistant illness require case-specific clinical and legal safeguards beyond this episode.

What Changed

• Created the boundary linking neural-control capability to autonomy, identity, consent, and proportionality.

Related Concepts

• Optogenetics - causal control method that makes the ethical question vivid.
• Selective Neural Stimulation Precision - technical precision requirement that does not by itself settle permission or goals.
• Deep Brain Stimulation Psychiatry - invasive clinical setting where benefit, risk, consent, and target uncertainty converge.
• Free Will / 自由意志 - broader philosophical question about agency under biological causation.
• Circuit-Based Psychiatry - mechanism framework whose interventions require an explicit agency boundary.
• Medical Risk Management - broader structure for proportionality, monitoring, and harm reduction.